AN ORAL REMINERALIZATION ACCELERATING COMPOSITION
20220110843 · 2022-04-14
Inventors
Cpc classification
A61Q11/00
HUMAN NECESSITIES
A61Q11/00
HUMAN NECESSITIES
International classification
Abstract
An oral remineralization accelerating composition includes: a first pH increasing component, sodium bicarbonate, having a concentration in the range from 1 to 10 weight/volume percent, preferably in the subrange from 2 to 5 weight/volume percent; sodium alginate, having a concentration in the range from 0.5 to 5 weight/volume percent; a bacteria saturating component, xylitol, having a concentration in the range from 10 to 80 weight/volume percent, preferably in the subrange from 20 to 40 weight/volume percent; and a critical pH decreasing component, either casein phosphopeptide or sodium fluoride, having a concentration in the range from 0.02 to 5 weight/volume percent, such that the critical pH of tooth structure is reduced to a value below 5.5.
Claims
1.-16. (canceled)
17. An oral remineralization accelerating composition comprising: a first pH increasing component wherein the first pH increasing component is selected to be sodium bicarbonate, having a concentration in the range from 1 to 10 weight/volume percent; sodium alginate, having a concentration in the range from 0.5 to 5.0 weight/volume percent; a bacteria saturating component wherein the bacteria saturating component is selected to be xylitol, having a concentration in the range from 10 to 80 weight/volume percent; and a critical pH decreasing component, wherein the critical pH decreasing component is selected from the group of casein phosphopeptide and sodium fluoride, having a concentration in the range from 0.02 to 5 weight/volume percent, such that the critical pH of enamel is reduced to a value below 5.5.
18. The oral remineralization accelerating composition according to claim 17, wherein the first pH increasing component is selected to be sodium bicarbonate, having a concentration of 2.5 weight/volume percent.
19. The oral remineralization accelerating composition according to claim 17, wherein the first pH increasing component is selected to be sodium bicarbonate, having a concentration of 4 weight/volume percent.
20. The oral remineralization accelerating composition according to claim 17, wherein sodium alginate has a concentration of 1 weight/volume percent.
21. The oral remineralization accelerating composition according to claim 17, wherein xylitol has a concentration of 30 weight/volume percent.
22. The oral remineralization accelerating composition according to claim 17, wherein said critical pH decreasing component is selected to be sodium fluoride, having a concentration of 0.05 weight/volume percent.
23. The oral remineralization accelerating composition according to claim 17, wherein said critical pH decreasing component is selected to be sodium fluoride, having a concentration of 0.0225 weight/volume percent.
24. The oral remineralization accelerating composition according to claim 17, wherein said critical pH decreasing component is selected to be casein phosphopeptide, having a concentration of 2 weight/volume percent.
25. The oral remineralization accelerating composition according to claim 17, further comprising: a second pH increasing component wherein the second pH increasing component is selected to be calcium carbonate, having a concentration in the range from 2 to 5 weight/volume percent.
26. The oral remineralization accelerating composition according to claim 25, wherein the second pH increasing component is selected to be calcium carbonate, having a concentration of 3 weight/volume percent.
27. The oral remineralization accelerating composition according to claim 17, further comprising: menthol having a concentration in the range from 0.2 to 1 weight/volume percent.
28. The oral remineralization accelerating composition according to claim 27, wherein menthol has a concentration of 0.5 weight/volume percent.
29. The oral remineralization accelerating composition according to claim 27, wherein menthol has a concentration of 0.3 weight/volume percent.
30. The oral remineralization accelerating composition according claim 17, further comprising: a tooth adhesive.
31. The oral remineralization accelerating composition according to claim 17, wherein said oral remineralization accelerating composition has the form of a mouth gel.
32. The oral remineralization accelerating composition according to claim 17, wherein said oral remineralization accelerating composition has the form of a mouth rinsing solution.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0050]
[0051]
[0052]
[0053]
[0054]
[0055]
[0056]
[0057]
DETAILED DESCRIPTION OF EMBODIMENT(S)
[0058] A first embodiment of the oral remineralization accelerating composition according to the invention consists of a mouth gel with following constitution:
[0059] purified water with a concentration of 19.50 weight/volume percent;
[0060] magnesium aluminium silicate with a concentration of 1.0 weight/volume percent;
[0061] sodium bicarbonate with a concentration of 2.5 weight/volume percent;
[0062] calcium carbonate with a concentration of 3.0 weight/volume percent;
[0063] sorbitol with a concentration of 24.57 weight/volume percent;
[0064] glycerin with a concentration of 12.442 weight/volume percent;
[0065] sodium alginate with a concentration of 1.0 weight/volume percent;
[0066] xylitol with a concentration of 30.0 weight/volume percent;
[0067] PEG-40 hydrogenated castar oil/propylene glycol with a concentration of 3.5 weight/volume percent;
[0068] menthol with a concentration of 0.5 weight/volume percent;
[0069] carprylyl glycol with a concentration of 0.5 weight/volume percent;
[0070] sodium fluoride with a concentration of 0.05 weight/volume percent;
[0071] citric acid 50% solution in water with a concentration of 0.058 weight/volume percent; and
[0072] sodium phosphate with a concentration of 1.38 weight/volume percent.
[0073] A second embodiment of the oral remineralization accelerating composition according to the invention consists of a mouth gel with following constitution:
[0074] purified water with a concentration of 19.50 weight/volume percent;
[0075] magnesium aluminium silicate with a concentration of 1.0 weight/volume percent;
[0076] sodium bicarbonate with a concentration of 2.5 weight/volume percent;
[0077] calcium carbonate with a concentration of 3.0 weight/volume percent;
[0078] sorbitol with a concentration of 22.62 weight/volume percent;
[0079] glycerin with a concentration of 12.442 weight/volume percent;
[0080] sodium alginate with a concentration of 1.0 weight/volume percent;
[0081] xylitol with a concentration of 30.0 weight/volume percent;
[0082] PEG-40 hydrogenated castar oil/propylene glycol with a concentration of 3.5 weight/volume percent;
[0083] menthol with a concentration of 0.5 weight/volume percent;
[0084] carprylyl glycol with a concentration of 0.5 weight/volume percent;
[0085] casein phosphopeptide or CPP with a concentration of 2.0 weight/volume percent;
[0086] citric acid 50% solution in water with a concentration of 0.058 weight/volume percent; and
[0087] sodium phosphate with a concentration of 1.38 weight/volume percent.
[0088] A third embodiment of the oral remineralization accelerating composition according to the invention consists of a mouth gel with following constitution:
[0089] purified water with a concentration of 57.012 weight/volume percent;
[0090] sodium alginate with a concentration of 1.0 weight/volume percent;
[0091] sodium bicarbonate with a concentration of 2.5 weight/volume percent;
[0092] calcium carbonate with a concentration of 3.0 weight/volume percent;
[0093] xylitol with a concentration of 30.0 weight/volume percent;
[0094] PEG-40 hydrogenated castar oil/propylene glycol with a concentration of 4.0 weight/volume percent;
[0095] menthol with a concentration of 0.5 weight/volume percent;
[0096] carprylyl glycol with a concentration of 0.5 weight/volume percent;
[0097] sodium fluoride with a concentration of 0.05 weight/volume percent;
[0098] citric acid 50% solution in water with a concentration of 0.058 weight/volume percent; and
[0099] sodium phosphate with a concentration of 1.38 weight/volume percent.
[0100] A fourth embodiment of the oral remineralization accelerating composition according to the invention consists of a mouth rinsing fluid with following constitution:
[0101] purified water with a concentration of 52.638 weight/volume percent;
[0102] ethyl alcohol with a concentration of 10.0 weight/volume percent;
[0103] menthol with a concentration of 0.3 weight/volume percent;
[0104] PEG-40 hydrogenated castar oil/propylene glycol with a concentration of 1.5 weight/volume percent;
[0105] sodium alginate with a concentration of 1.0 weight/volume percent;
[0106] sodium anisate with a concentration of 0.5 weight/volume percent;
[0107] sodium saccharin with a concentration of 0.03 weight/volume percent;
[0108] sodium fluoride with a concentration of 0.0225 weight/volume percent;
[0109] sodium bicarbonate with a concentration of 4.0 weight/volume percent;
[0110] xylitol with a concentration of 30.0 weight/volume percent; and
[0111] CI 42090 aquatic solution with a concentration of 0.01 weight/volume percent.
[0112] It is noticed that in the above described embodiments, the weight/volume percentage of sodium alginate may be increased to levels above 1 weight/volume percent, in replacement of an equivalent weight/volume percentage of purified water. The weight/volume percentage of sodium alginate may also be decreased to levels below 1 weight/volume percent and be replaced by an equivalent weight/volume percentage of xanthan gum.
[0113]
[0114]
[0115] The evolution over time of the pH of tooth plaque 103 after an acid attack is reflected in Stephan's curve 201, shown in
[0116] The human's saliva neutralizes the pH of tooth plaque 103 through diffusion. This natural defence mechanism against acid attacks is known as remineralization. As is illustrated by
[0117]
[0118]
[0119]
[0120]
[0121]
[0122]
[0123] It is noticed that a possible synergistic effect of the combined presence of both CPP and sodium fluoride in embodiments of the oral remineralization accelerating composition according to the invention requires further clinical research.
[0124] Although the present invention has been illustrated by reference to specific embodiments, it will be apparent to those skilled in the art that the invention is not limited to the details of the foregoing illustrative embodiments, and that the present invention may be embodied with various changes and modifications without departing from the scope thereof. The present embodiments are therefore to be considered in all respects as illustrative and not restrictive, the scope of the invention being indicated by the appended claims rather than by the foregoing description, and all changes which come within the meaning and range of equivalency of the claims are therefore intended to be embraced therein. In other words, it is contemplated to cover any and all modifications, variations or equivalents that fall within the scope of the basic underlying principles and whose essential attributes are claimed in this patent application. It will furthermore be understood by the reader of this patent application that the words “comprising” or “comprise” do not exclude other elements or steps, that the words “a” or “an” do not exclude a plurality, and that a single element, such as a computer system, a processor, or another integrated unit may fulfill the functions of several means recited in the claims. Any reference signs in the claims shall not be construed as limiting the respective claims concerned. The terms “first”, “second”, third“, “a”, “b”, “c”, and the like, when used in the description or in the claims are introduced to distinguish between similar elements or steps and are not necessarily describing a sequential or chronological order. It is to be understood that the terms so used are interchangeable under appropriate circumstances and embodiments of the invention are capable of operating according to the present invention in other sequences, or in orientations different from the one(s) described or illustrated above.